Warum Bitcoin als Wertspeicher in keinem diversifizierten Portfolio fehlen sollte. Jetzt lesen -w-
27.03.2017 23:39:00

Shareholder Alert: Monteverde & Associates PC Announces An Investigation Of ADMA Biologics, Inc. - ADMA

NEW YORK, March 27, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating  ADMA Biologics, Inc. ("ADMA" or the "Company")(NasdaqGS: ADMA)  and its Board of Directors for potential securities laws violations and/or breaches of fiduciary duties in connection with the Purchase Agreement with Biotest Pharmaceuticals Corporation for its therapy business (the "Purchase Agreement").  

Click here for more information: http://monteverdelaw.com/investigations/m-a/.  It is free and there is no cost or obligation to you.

The investigation focuses on whether ADMA and/or its Board of Directors violated federal securities laws and/or breached their fiduciary duties to the Company's stockholders by 1) failing to properly value the Purchase Agreement and 2) failing to disclose all material information in connection with the Purchase Agreement.

Monteverde & Associates PC is a boutique class action securities and consumer litigation law firm that has recovered millions of dollars and iscommitted to protecting shareholders and consumers from corporate wrongdoing.  Monteverde & Associates PC lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions, whereby they protect investors by recovering money and remedying corporate misconduct.

If you own common stock in ADMA and wish to obtain additional information and protect your investments free of charge, please visit us at www.monteverdelaw.com/investigations/m-a/  or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. 59th Floor
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341

Attorney Advertising. (C) 2017 Monteverde & Associates PC.  The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com).  Prior results do not guarantee a similar outcome with respect to any future matter.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-monteverde--associates-pc-announces-an-investigation-of-adma-biologics-inc---adma-300429961.html

SOURCE Monteverde & Associates PC

Analysen zu ADMA Biologics Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

ADMA Biologics Inc 21,82 1,63% ADMA Biologics Inc